跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ALBUREX 25 AU Human Albumin 250 g/L (25% w/v) 50 mL solution for intravenous infusion vial
Approved
STANDARD
ALBUREX 25 AU Human Albumin 250 g/L (25% w/v) 50 mL solution for intravenous infusion vial
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d0a66c29a0193b9a
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
d0a66c29a0193b9a
Product Name
ALBUREX 25 AU Human Albumin 250 g/L (25% w/v) 50 mL solution for intravenous infusion vial
Artg Id
327954
Artg Name
ALBUREX 25 AU Human Albumin 250 g/L (25% w/v) 50 mL solution for intravenous infusion vial
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2020-07-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d0a66c29a0193b9a
Type
Standard
Back to TGA Approvals
ALBUREX 25 AU Human Albumin 250 g/L (25% w/v) 50 mL solution for intravenous infusion vial - TGA Drug Approval Details